Cadila Healthcare trades in green on the bourses

10 Dec 2020 Evaluate

Cadila Healthcare is currently trading at Rs. 469.05, up by 0.95 points or 0.20% from its previous closing of Rs. 468.10 on the BSE.

The scrip opened at Rs. 467.10 and has touched a high and low of Rs. 475.25 and Rs. 464.30 respectively. So far 124373 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 480.70 on 07-Dec-2020 and a 52 week low of Rs. 212.70 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 480.70 and Rs. 457.95 respectively. The current market cap of the company is Rs. 47941.87 crore.

The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 16.88% and 8.05% respectively.

Zydus Cadila has been granted Fast Track Designation by the United States Food and Drug Administration (USFDA) for Saroglitazar Mg for the treatment of patients with Primary Biliary Cholangitis (PBC). Fast Track is a process of the USFDA which expedites the review of drugs to treat serious conditions and fill an unmet medical need. A drug that receives Fast Track designation is eligible for Accelerated Approval and Priority Review, if the relevant criteria are met. The global market for primary biliary cholangitis treatment is expected to grow at a CAGR of 36.3% from 2018 - 2026 and is expected to reach $10.8 billion by 2026 as per Coherent market insights.

Saroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist. Results of phase 2, prospective multicentre randomized double-blind, placebocontrolled study to evaluate the safety, tolerability and efficacy of Saroglitazar Mg in patients with Primary Biliary Cholangitis (EPICS) was presented earlier at the The Liver Meeting 2020, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD).

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×